[go: up one dir, main page]

FI863677A0 - Polydispersa nativa pseudomonas-flagella(h)-antigener (fag) samt foerfarande foer framstaellning daerav. - Google Patents

Polydispersa nativa pseudomonas-flagella(h)-antigener (fag) samt foerfarande foer framstaellning daerav.

Info

Publication number
FI863677A0
FI863677A0 FI863677A FI863677A FI863677A0 FI 863677 A0 FI863677 A0 FI 863677A0 FI 863677 A FI863677 A FI 863677A FI 863677 A FI863677 A FI 863677A FI 863677 A0 FI863677 A0 FI 863677A0
Authority
FI
Finland
Prior art keywords
flagellar
antigens
pct
fag
pseudomonas
Prior art date
Application number
FI863677A
Other languages
English (en)
Other versions
FI85221C (fi
FI85221B (fi
FI863677A7 (fi
Inventor
Thomas C Montie
Friedrich Dorner
James L Mcdonel
Artur Mitterer
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI863677A7 publication Critical patent/FI863677A7/fi
Publication of FI863677A0 publication Critical patent/FI863677A0/fi
Application granted granted Critical
Publication of FI85221B publication Critical patent/FI85221B/fi
Publication of FI85221C publication Critical patent/FI85221C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI863677A 1985-01-14 1986-09-11 Foerfarande foer framstaellning av nya nativa pseudomonas-flagella(h)-antigener. FI85221C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT7285 1985-01-14
AT0007285A AT384032B (de) 1985-01-14 1985-01-14 Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
AT8600002 1986-01-13
PCT/AT1986/000002 WO1986003974A1 (fr) 1985-01-14 1986-01-13 ANTIGENES-FLAGELLA(H) DE PSEUDOMONAS (FAg) POLYDISPERSES NATIFS ET PROCEDES POUR LEUR PREPARATION

Publications (4)

Publication Number Publication Date
FI863677A7 FI863677A7 (fi) 1986-09-11
FI863677A0 true FI863677A0 (fi) 1986-09-11
FI85221B FI85221B (fi) 1991-12-13
FI85221C FI85221C (fi) 1992-03-25

Family

ID=3480790

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863677A FI85221C (fi) 1985-01-14 1986-09-11 Foerfarande foer framstaellning av nya nativa pseudomonas-flagella(h)-antigener.

Country Status (10)

Country Link
US (1) US4831121A (fi)
EP (1) EP0208743B1 (fi)
JP (1) JPH085801B2 (fi)
AT (2) AT384032B (fi)
CA (1) CA1263307A (fi)
DE (1) DE3686961D1 (fi)
DK (1) DK172329B1 (fi)
ES (1) ES8800275A1 (fi)
FI (1) FI85221C (fi)
WO (1) WO1986003974A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US4994161A (en) * 1989-02-02 1991-02-19 University Of New Hampshire Apparatus and method for macromolecular charge determination
RU2147317C1 (ru) * 1999-08-12 2000-04-10 Научно-исследовательский институт пушного звероводства и кролиководства им.В.А.Афанасьева Штамм бактерий pseudomonas aeruginosa 4992, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169764C2 (ru) * 1999-08-12 2001-06-27 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 5132, используемый для изготовления вакцины против псевдомоноза пушных зверей
JP2007530029A (ja) * 2004-03-26 2007-11-01 クアーク・ファーマスーティカルス、インコーポレイテッド アネキシンｉｉ及びその使用
US8263078B2 (en) 2007-09-05 2012-09-11 Inotek Pharmaceuticals Corporation Antibodies against flagellin and uses thereof
US20100239583A1 (en) * 2009-03-04 2010-09-23 Inotek Pharmaceuticals Corporation Antibodies against flagellin and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928565A (en) * 1971-10-19 1975-12-23 Yuzuru Homma Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
JPS51133489A (en) * 1975-05-14 1976-11-19 Tokyo Daigaku Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
US4271147A (en) * 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
EP0048422A3 (en) * 1980-09-15 1983-08-24 Bactex Incorporated Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa
US4470924A (en) * 1981-12-30 1984-09-11 Iglewski Barbara M Nontoxic, immunologically crossreactive toxin A protein from Pseudomonas aeruginosa
US4578458A (en) * 1983-03-23 1986-03-25 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa

Also Published As

Publication number Publication date
CA1263307C (en) 1989-11-28
JPS62501363A (ja) 1987-06-04
DK172329B1 (da) 1998-03-23
DK421486A (da) 1986-09-03
AT384032B (de) 1987-09-25
DK421486D0 (da) 1986-09-03
ES550831A0 (es) 1987-11-01
CA1263307A (en) 1989-11-28
FI85221C (fi) 1992-03-25
FI85221B (fi) 1991-12-13
ATE81471T1 (de) 1992-10-15
ATA7285A (de) 1987-02-15
US4831121A (en) 1989-05-16
WO1986003974A1 (fr) 1986-07-17
EP0208743B1 (de) 1992-10-14
EP0208743A1 (de) 1987-01-21
ES8800275A1 (es) 1987-11-01
DE3686961D1 (de) 1992-11-19
FI863677A7 (fi) 1986-09-11
JPH085801B2 (ja) 1996-01-24

Similar Documents

Publication Publication Date Title
ES2071706T3 (es) Metodo para fraccionar proteinas plasmaticas.
DK371087D0 (da) Mamalialt interleukin-4
PE15297A1 (es) Proteinas anti-obesidad
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
AR052377A2 (es) Polipeptidos y polinucleotidos de neisseria meningitidis, un huesped unicelular, un metodo para producir una secuencia de adn, un metodo para producir un polipeptido, un metodo para aislar el antigeno, una composicion farmaceutica, uso de una proteina para producir una vacuna destinada para la preve
DE3876401D1 (de) N-terminale fragmente von menschlichem serumalbumin.
DE58900776D1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
FI863677A0 (fi) Polydispersa nativa pseudomonas-flagella(h)-antigener (fag) samt foerfarande foer framstaellning daerav.
SE8801701D0 (sv) Production technology based on enzymic method
Hoffman Allergens in Hymenoptera venom XIII: Isolation and purification of protein components from three species of vespid venoms
DE3686954D1 (de) Loeslichkeits-, reinigungs- und charakterisierungsverfahren fuer proteine aus unloeslichen proteinaggregaten oder proteinkomplexen und diesbezuegliche praeparate.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
Omori-Satoh et al. A simple and rapid method for separating two hemorrhagic principles in the venom of Trimeresurus flavoridis
DE3585713D1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
DK412389D0 (da) Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
PT87001A (pt) Processo para a preparacao de uma vacina contra a disenteria suina e fins analogos
NZ209588A (en) Production of human immune interferon and pharmaceutical composition
PT85248A (fr) Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants
BG44873A3 (bg) Метод за получаване на кондензирани аs-триазини
ES2074935A1 (es) Proteina ebulina 1 de la planta sambucus ebulus l., procedimiento para su obtencion y su utilizacion.
CA1264148C (en) HYDROXYPALATITE FOR THE ANALYSIS AND PREPARATION OF PURIFIED MONOCLONAL ANTIBODIES

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: IMMUNO AKTIENGESELLSCHAFT